PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 26, 2025Frontiers in Microbiology5 citationsOpen Access

Microbial prodigiosin shows broad-spectrum bioactivity confirmed by experimental and computational analyses

View Full Paper
MRMuhammad RafiqNHNoor ul HudaNHNoor Hassan

Key Points

  • Prodigiosin exhibited strong antibacterial effects against Escherichia coli and Bacillus subtilis, indicating broad-spectrum bioactivity.
  • Antioxidant analysis revealed a radical-scavenging activity of up to 37.5% at a concentration of 1000 μg/mL.
  • Molecular docking identified high binding affinities with key target sites for antioxidant, antifungal, and antibacterial mechanisms.
  • The optimized production process using peptone meat extract enhanced yield, highlighting its potential for industrial applications.

Abstract

The growing demand for natural bioactive compounds highlights the need for antimicrobial and antioxidative metabolites derived from microbial sources. Among them, prodigiosin, a red pigment from Serratia marcescens , displays potent antioxidant and antimicrobial properties. However, optimizing its production and understanding molecular interactions remain challenging. In this study, we identified an optimized process for enhanced yield using peptone meat extract (PM) media at an incubation temperature of 30 °C, which notably outperformed other tested conditions and media. The purified red pigment was further characterized by column and thin-layer chromatography, UV–visible spectrophotometry, Fourier Transform Infrared (FT-IR) spectroscopy, and Mass Spectrometry (ESI-MS/MS). The pigment demonstrated an R f value of 0.93 through column chromatography and TLC. The structural characteristics were established using UV–Vis (λ max 536 nm), FT-IR, and ESI-MS/MS (m/z 324.3 amu), consistent with the prodiginine family. The characterized and purified prodigiosin showed excellent antibacterial activity against Gram-negative bacteria Escherichia coli (28.2 ± 0.57 mm) and Gram-positive bacteria Bacillus subtilis (23.58 ± 0.6 mm), together with antifungal activity against Fusarium oxysporum and Aspergillus niger . Antioxidant analysis showed a dose-dependent radical-scavenging activity of up to 37.5% at 1000 μg/mL. To understand the mechanistic pathways, molecular docking revealed high binding affinities of the produced metabolite with key target sites as FKS1 (−7.2 kcal/mol) for antifungal inhibition, FabH (−7.3 kcal/mol) against antibacterial inhibition, and Keap1 (−8.3 kcal/mol) for antioxidant activity. Our findings not only feature prodigiosin’s broad-spectrum bioactivity but also offer its interaction with molecular targets, providing the basis for developing this metabolite as a natural therapeutic agent in multiple industrial applications, including pharmaceuticals and agriculture.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Rafiq et al. (2025) studied this question.

synapsesocial.com/papers/68d6cd63b1249cec298b35d9https://doi.org/10.3389/fmicb.2025.1676959
Ask AI
Helpful
Bookmark
Share
View Full Paper